Duhuo Jisheng Decoction Mitigates Intervertebral Disc Degeneration via Metabolic Reprogramming and TGF‐β/Smad‐Driven Autophagy‐Fibrosis Network Modulation
Biomedical Chromatography · 2026-08 · 40 (8)
DOI: 10.1002/bmc.70530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 01.07.2026. Verfasst von Chao Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Second Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning City, Guangxi Zhuang Autonomous Region, …. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Intervertebral Disc Degeneration, Autophagy, Transforming Growth Factor beta. Die Arbeit nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Duhuo Jisheng Decoction (DHJSD) shows promise for treating intervertebral disc degeneration (IVDD), but its mechanisms concerning autophagy and fibrosis are unclear. Using network pharmacology, metabolomics, UHPLC‐Q‐TOF/MS, and functional studies (in vitro and in vivo), we systematically explored DHJSD's molecular mechanisms. DHJSD has 254 constituents; those may regulate inflammation, apoptosis, and metabolic processes. DHJSD attenuates ECM/fibrosis‐related changes, lowers BMP2 expression, is associated with reduced TGF‐β/Smad2/3 phosphorylation, and partially improves annulus fibrosus morphology. SB431542 attenuated IL‐1β‐induced TGF‐β pathway activation and BMP2 expression, supporting the involvement of this pathway in DHJSD‐related regulation of fibrosis markers. The levels of serum IL‐1β and TNF‐α significantly decreased in animal models. Through glycerophospholipid and sphingolipid metabolism, DHJSD reshapes lipid homeostasis and may be associated with reduced TGF‐β overactivation by downregulating pro‐fibrotic compounds and upregulating anti‐inflammatory metabolites. DHJSD modulates autophagy‐related markers via controlling the LC3‐II/LC3‐I ratio and BCL2, P62 expression. DHJSD may affect glycolysis‐related and oxidative phosphorylation‐related changes and may be associated with phosphatidylcholine/ethanolamine‐related mitochondrial membrane changes. DHJSD treats IVDD via a “metabolic reprogramming–TGF‐β‐related regulation–autophagy/mitochondrial‐related remodeling” network, suggesting a potential multi‐target strategy and demonstrating the value of multi‐omics in analyzing traditional medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The Second Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning City, Guangxi Zhuang Autonomous Region, China.
- Department of Orthopedics and Traumatology (Trauma and Bone-setting), The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan Province, China.
- Department of Orthopedics, Guigang Integrated Traditional Chinese and Western Medicine Orthopedic Hospital, Nanning, Guangxi, China.
ORCID-Profile: Chao Song, Fei Liu, Zongchao Liu, Feng Chen, Hui Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Song, C., Wu, X., Chen, C., Wang, X., Liu, F., Liu, Z., Chen, F., & Wang, H. (2026). Duhuo Jisheng Decoction Mitigates Intervertebral Disc Degeneration via Metabolic Reprogramming and TGF‐β/Smad‐Driven Autophagy‐Fibrosis Network Modulation. Biomedical Chromatography, 40(8). https://doi.org/10.1002/bmc.70530
Vancouver
Song C, Wu X, Chen C, Wang X, Liu F, Liu Z, et al. Duhuo Jisheng Decoction Mitigates Intervertebral Disc Degeneration via Metabolic Reprogramming and TGF‐β/Smad‐Driven Autophagy‐Fibrosis Network Modulation. Biomedical Chromatography. 2026;40(8). doi:10.1002/bmc.70530
BibTeX
@article{Song2026,
author = {Song, Chao and Wu, Xiaofei and Chen, Chaoqi and Wang, Xiaoqiang and Liu, Fei and Liu, Zongchao and Chen, Feng and Wang, Hui},
title = {Duhuo Jisheng Decoction Mitigates Intervertebral Disc Degeneration via Metabolic Reprogramming and TGF‐β/Smad‐Driven Autophagy‐Fibrosis Network Modulation},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {8},
doi = {10.1002/bmc.70530}
}
EUVIMED